Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IONQ vs MRNA✓SelectedUSD · MRNAIONQ vs MRNA performance historyLatest closeAs of-8.76%11/20
Stock and ETF performance explorer

IONQ vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-10.6%
MRNA return
-27.3%
Excess return
+16.6%
Maximum drawdown
-88.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.8%-2.2%-6.6%-8.4%
7D-28.3%-12.7%-15.6%-26.7%
30D-35.8%-20.7%-15.1%-33.5%
3M-50.1%+46.3%-96.4%-52.9%
6M-60.5%+305.2%-365.7%-74.5%
YTD-53.8%+561.2%-615.1%-75.9%
1Y-49.5%+772.1%-821.6%-76.4%
3Y+61.2%+147.0%-85.7%+8.7%
All-10.6%-27.3%+16.6%-21.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling